1 February 2023 - From 1 February, Australians with Parkinson’s disease will have access to a new medicine on the PBS. ...
31 January 2023 - 31 January is set to mark the start of a watershed year for the biosimilars industry ...
1 February 2023 - The February 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
1 February 2023 - The February 2023 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
31 January 2023 - Four years of real world experience in more than 300,000 patients and over 60 countries. ...
31 January 2023 - Sarah Lee has been forced to use her super and life insurance to pay for the treatment. ...
23 January 2023 - Mila was diagnosed with cystic fibrosis aged just one, after experiencing lung failure in hospital, and ...
22 January 2023 - This week, PHARMAC announced it was looking to fund a second drug to treat the neurological ...
20 January 2023 - RemeGen is pleased to announce that as of 18 January 2023, two indications for the Company's ...
18 January 2023 - Ascentage Pharma and Innovent Biologics today announced that the novel drug olverembatinib has been included into the ...
19 January 2023 - Set against the backdrop of current debates about lowering drug costs, lowering the price of insulin—a lifesaving ...
19 January 2023 - China will add 111 drugs to its national medical reimbursement list this year, with a focus ...
18 January 2023 - Innovent Biologics today announced that, five products (including new indications) of the company have been included in ...
17 January 2023 - Tascenso ODT is now approved by the US FDA as a bioequivalent to Gilenya (fingolimod hydrochloride), for ...
18 January 2023 - Zai Lab today announced that the National Reimbursement Drug List released by China’s National Healthcare Security Administration ...